Case Report: Temporal dissociation between peripheral B-cell pharmacodynamics and renal remission during sequential rituximab and telitacicept-containing therapy in childhood secondary steroid-resistant nephrotic syndrome
Rituximab (RTX) can improve outcomes in children with frequently relapsing or steroid-dependent nephrotic syndrome, although a marked reduction in circulating B cells does not invariably coincide with renal remission. We report a girl who developed fre…